Aditum Bio is a new model of biotech venture capital uniquely positioned to rapidly translate scientific discoveries into innovative new medicines. Aditum brings together unmatched scientific and domain expertise, combined with operational capabilities. Our agile operating model enables rapid company formation, planning, and execution for a new model of drug development. We target clinic-ready therapies to help underserved patient populations, forming companies and staffing them with medical and scientific experts. Launched in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for Biomedical Research, Dr. Mark Fishman, Aditum currently manages a broad portfolio of clinical stage companies with multiple drug candidates in or entering Phase 2 clinical trials.

Position Summary:

The Senior Associate will work with Aditum Bio partners to identify new investment opportunities and support the due diligence process on those opportunities, including modeling and simulation. The associate will play an important role throughout the investment lifecycle, supporting activities from defining initial areas of interest, to aiding in diligence and deal negotiations and transactions, to new company formation.

Specific Responsibilities:

• Propose ideas for potential investments. The associate will research various pathways and indications, form investment theses and vet those theses with Aditum Partners, Advisors and externally curated experts.
• Perform research to help identify new investment opportunities. To evaluate drug assets of interest to Aditum Bio, the associate will develop and engage with key contacts and prospects in order to access drug assets that may be of interest to the Aditum Bio investment team.
• Scientific review panels: Work closely with Aditum Bio partners and scientific advisors to discuss interim findings. Use discussions and feedback to iterate on research and recommendations.
• Deal diligence and transactions: Conduct due diligence on therapies of interest, including scientific, clinical, and financial. Work with functional Aditum Bio experts to develop clinical strategies, development plans, and budgets. Present findings at Aditum Bio Investment Committee. Work with external partners on deal discussions and transactions.
• New Company Incubation and Operations: Help lead new company incubation and operations for assets in licensed. Translate the clinical and scientific findings from investment generation into the new companies formed. 

Qualifications:

• MD, PhD, or an MD/PhD
• 2-4 years of experience in management consulting, venture capital or investment banking
• Experience in the life sciences
• The ability to perform in-depth industry due diligence and data analysis
• Experience working cross functionally to develop clinical strategies, development plans and budgets
• Strong track record in effectively working with senior management
• Proven ability to work collaboratively internally and externally, with the ability to manage multiple stakeholders

Location requirements: This is a hybrid role (2-3 days per week onsite) and can be based from our headquarters in Oakland, California or from Cambridge, Massachusetts. Aditum Bio intends to open an office location in Cambridge in Q3 2024; the position would be fully remote for those MA-based until a Cambridge office opening.